Tesamorelin 10 mg

Análogo estabilizado de la hormona liberadora de hormona de crecimiento, estudiado por sus efectos sobre el tejido adiposo visceral y la actividad del eje IGF-1 en modelos de investigación.

Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) — modified to extend its half-life relative to native GHRH. It is one of the most studied GHRH-analogue research peptides and the only one of its class to have undergone regulatory approval in any jurisdiction (for HIV-associated lipodystrophy, in the US, under the brand name Egrifta). Quantum Labs supplies Tesamorelin as a lyophilised powder for Australian research applications.

Research on Tesamorelin has covered models of growth-hormone secretion, body composition, lipid metabolism, and IGF-1 dynamics. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.

Mecanismo

Estudiado por la unión selectiva al receptor de GHRH con vida media prolongada. Investigación asociada con la reducción de marcadores de grasa visceral y con la elevación de IGF-1 en poblaciones de estudio.